Lataa...
Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer
Background: Irinotecan (CPT-11) can be used as a first-line therapeutic drug against extensive-stage small cell lung cancer (SCLC); it can also be used in second-line treatment for SCLC. CPT-11-induced delayed diarrhea restricts its clinical application. This study aimed to confirm whether Banxia Xi...
Tallennettuna:
| Julkaisussa: | Integr Cancer Ther |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6247536/ https://ncbi.nlm.nih.gov/pubmed/30229683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735418801532 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|